Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Canntab IR CBD tablet
- Development stage
- Unknown
- Lead developer
- Canntab Therapeutics
- Modality
- Small Molecules
- Administration
- Oral
01
Overview
Canntab IR CBD tablet (marketed as Instacann CBD) is an instant-release, solid oral dosage formulation of cannabidiol (CBD) developed by Canntab Therapeutics. Utilizing proprietary nano-emulsification and granulation technologies, the hard tablet is designed to overcome the bioavailability and dosing precision challenges of traditional oil-based CBD formulations. Cannabidiol exerts its therapeutic effects through a complex, multimodal mechanism of action, including negative allosteric modulation of cannabinoid CB1 and CB2 receptors, agonism of serotonin 5-HT1A and TRPV1 receptors, and antagonism of GPR55. The product is approved and marketed in Canada for medical cannabis patients seeking relief from pain, inflammation, and anxiety.
- Brand names
- Instacann CBD
- Other names
- CBD tabletInstant Release CBD tablet
02
Targets
HTR1A (Serotonin receptor 1A (5-hydroxytryptamine receptor 1A))CNR1 (Cannabinoid receptor 1)GPR55 (G protein-coupled receptor 55)PPARG (Peroxisome proliferator-activated receptor gamma)TRPV1 (Transient receptor potential cation channel subfamily V member 1)
Beyond the preview
Go deeper on Canntab IR CBD tablet.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Canntab IR CBD tablet.